EGFR and non-small cell lung carcinoma: In our series of 20 primary NSCLC and 13 mCRC, CISH evidenced EGFR gene amplification only in NSCLC (2/20, 10%) and an elevated incidence of high polysomy (40% NSCLC and 53% mCRC).